C07C 279/12
Being further substituted by nitrogen atoms not being part of nitro or
Official title: being further substituted by nitrogen atoms not being part of nitro or nitroso groups
C07C279/12 (Being further substituted by nitrogen atoms not being part of nitro or) appears on 182 US grants and 178 published applications in this corpus.
Search patents in C07C- Granted patents
- 182
- Published applications
- 178
- Assignees
- 137
- Inventors
- 508
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 8 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 6 | 0 |
| 1999 | 5 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 4 | 0 |
| 2003 | 3 | 5 |
| 2004 | 1 | 1 |
| 2005 | 3 | 10 |
| 2006 | 2 | 2 |
| 2007 | 0 | 1 |
| 2008 | 1 | 3 |
| 2009 | 2 | 4 |
| 2010 | 4 | 11 |
| 2011 | 3 | 10 |
| 2012 | 7 | 7 |
| 2013 | 4 | 9 |
| 2014 | 11 | 13 |
| 2015 | 5 | 4 |
| 2016 | 8 | 9 |
| 2017 | 7 | 15 |
| 2018 | 18 | 19 |
| 2019 | 9 | 8 |
| 2020 | 6 | 8 |
| 2021 | 6 | 10 |
| 2022 | 3 | 7 |
| 2023 | 6 | 6 |
| 2024 | 9 | 6 |
| 2025 | 8 | 5 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same30 Sep 2025US 12,427,346 B2Autotac Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents2 Sep 2025US 12,404,232 B2ModernaTX, Inc.
- Non-peptidic cell-penetrating motifs2 Sep 2025US 12,404,236 B2Ohio State Innovation Foundation
- Enzyme-cleavable methadone prodrugs and methods of use thereof12 Aug 2025US 12,384,744 B2Ensysce Biosciences Inc.
- Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disorders5 Aug 2025US 12,378,198 B2Arena Pharmaceuticals, Inc.
- Lipid compound and composition for delivery of active substance2 Jul 2026US 2026/0184669 A1Korea Research Institute of Bioscience and Biotechnology
- Anion Exchange Separation Article, Methods of Making, and Methods of Using14 May 2026US 2026/0131289 A1Solventum Intellectual Properties Company
- Compounds and compositions for intracellular delivery of therapeutic agents19 Mar 2026US 2026/0078082 A1ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents12 Mar 2026US 2026/0069549 A1ModernaTX, Inc.
- Cationic Surfactants with Improved pH Stability and Their Use29 Jan 2026US 2026/0028552 A1Locus Solutions Ipco, LLC
Most cited
By later US patents
- Methods for identifying RNA binding compounds220US 6,503,713 B1University of Medicine and Dentistry of New Jersey · 2003
- Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds149US 5,965,434 A1999
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Carrier ampholytes of high pH range95US 7,022,214 B2Bio-Rad Laboratories, Inc. · 2006
- Compounds and compositions for intracellular delivery of therapeutic agents88US 10,857,105 B2MordernaTX, Inc. · 2020